Main menu
Functional assessment: |
||
Adaptive immunity: |
||
Clinical manifestations |
Tests |
|
B- |
Usually onset age around 5- |
CBC/Differential , Quantitative IgM, IgG, IgA, & IgE; IgG subclass (L72- |
T- |
Usually onset age around below 2 months; Pneumocystis jroveci (carinii) pneumonia; Fungal infections; GVHD (rash, abnormal liver function tests and chronic diarrhea); Recurrent, severe, or unusual viral infections; Failure to thrive. |
CBC/Differential, T & B cell subset analysis |
Innate immunity: |
||
Clinical manifestations |
Tests |
|
PMN defects |
Usually onset age in neonatal stage; Soft tissue abscesses or lymphadenitis; Infection with catalase +organisms (Staph aureus, Serratia, E. coli, Aspergillus); Poor wound healing; Delayed separation of the umbilical cord; Chronic gingivitis and periodontal disease; Mucosal ulcerations. |
CBC/Differential, Neutrophil oxidative burst assay H2O2 production (M32- |
NK defects |
Usually combine with other PIDs; Recurrent herpesvirus infection (including EBV, CMV, varicella, herpes simplex virus); Hemophagocytic syndrome. |
Cytotoxicity (M32- |
Complement defects |
Recurrent disseminated Neisserial infections; Pyogenic bacterial infections; Angioedema of face, hands, feet, or GI tract; Autoimmune symptoms (Lupus); History suggestive of autosomal dominant inheritance. |
CH50, AH50, MBL –tests, complement cascade function first CH50- |